GBA1 and Parkinson disease: Two compounds, NCGC758 and NCGC607, have been shown to improve GCase trafficking and rescue glycosphingolipid and alpha-synuclein accumulation in iPSC-derived dopamine neurons from GBA1-PD patients (99, 100).